Caricamento...

The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis

INTRODUCTION: The objective of this pilot study was to compare cerebral gray matter (GM) atrophy over 1 year in patients starting dimethyl fumarate (DMF) for multiple sclerosis (MS) to that of patients on no disease-modifying treatment (noDMT). DMF is an established therapy for relapsing–remitting (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurol Ther
Autori principali: Dupuy, Sheena L., Tauhid, Shahamat, Hurwitz, Shelley, Chu, Renxin, Yousuf, Fawad, Bakshi, Rohit
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5130921/
https://ncbi.nlm.nih.gov/pubmed/27744504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-016-0054-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !